Commercial

Publication of Iveco Group’s results from Continuing Operations for 2022 and 2023 by Business Unit

Retrieved on: 
Monday, April 8, 2024
EXM, ASTRA, Small Business Saturday, Iveco, Agriculture, Financial services, IDV, Commercial, FPT Industrial, Adjustment, IVG, IVECO, Fire, Revenue

Iveco Group (EXM: IVG) announces the publication on its corporate website of its quarterly figures for 2022 and 2023 duly recast according to the Company’s new segment reporting structure by Business Unit, as presented on 14th March 2024 and effective starting from 1st January 2024.

Key Points: 
  • Iveco Group (EXM: IVG) announces the publication on its corporate website of its quarterly figures for 2022 and 2023 duly recast according to the Company’s new segment reporting structure by Business Unit, as presented on 14th March 2024 and effective starting from 1st January 2024.
  • Following the agreement with Mutares SE & Co. KGaA (ISIN: DE000A2NB650) regarding the divestiture of the Fire Fighting business, as of the first quarter of 2024 this Business Unit will be classified as “Discontinued Operations”.
  • Iveco Group N.V. (EXM: IVG) is the home of unique people and brands that power your business and mission to advance a more sustainable society.
  • Iveco Group employs more than 36,000 people around the world and has 20 industrial sites and 29 R&D centres.

Syntec Optics (Nasdaq: OPTX) to Showcase Advanced Imaging and Sensing Technologies at SPIE Defense + Commercial Sensing 2024

Retrieved on: 
Friday, April 5, 2024
LEO, Communication, Biomedicine, Original equipment manufacturer, Acquisition, Commercial, DCS, Defense

At booth #938, Syntec Optics will demonstrate its latest breakthroughs, engage with valued customers, and ignite further partnerships within the vibrant defense and sensing community.

Key Points: 
  • At booth #938, Syntec Optics will demonstrate its latest breakthroughs, engage with valued customers, and ignite further partnerships within the vibrant defense and sensing community.
  • "Syntec Optics has announced and launched several new products for existing markets and customers using existing capabilities," said Sara Hart, Director of Sales at Syntec Optics.
  • Ultra-Precision Biomedical Optics: Revolutionize medical imaging and diagnostics with Syntec Optics' state-of-the-art biomedical optics solutions.
  • Visit Syntec Optics at booth #938 during DCS 2024 to immerse yourself in a world of transformative light-based technologies.

Uber Freight Bolsters Executive Team with Industry Veterans Dan Annunziata and Hany Elkordy to Drive Market Expansion

Retrieved on: 
Wednesday, April 3, 2024
Last mile, Convoy, Truckload shipping, Growth, Amazon, Transport, LTL, Business, Magic, Small business, Commercial, Head, Intermodal transport, Heart, 3PL, Last, Amazon (company), Norfolk Southern Railway

Joining the Uber Freight family Dan Annunziata, appointed as Head of Commercial, and Hany Elkordy, assuming leadership of the Last Mile division.

Key Points: 
  • Joining the Uber Freight family Dan Annunziata, appointed as Head of Commercial, and Hany Elkordy, assuming leadership of the Last Mile division.
  • “Uber Freight has a compelling value proposition for shippers of all types; long gone are the days of the perceived digital startup,” said Dan Annunziata.
  • In his new role at Uber Freight, Hany will spearhead parcel modality enhancements and expansion, working closely with product, operations, and technology teams.
  • “Uber Freight is uniquely positioned to expand its logistics solutions into the Final Mile space,” said Hany Elkordy.

Perma-Fix Successfully Completes Pilot Plant Testing and Unveils New Process for Destruction of PFAS “Forever Chemicals”

Retrieved on: 
Wednesday, April 3, 2024
AFFF, Pregnancy, Centofanti, Obesity, Pressure, PFAS, Incineration, Environment, Cancer, Water pollution, Puberty, Risk, Calcium fluoride, Research, History, PESI, Fertility, Prostate, Commercial, Human, Chemistry, Infection, Ecosystem, Water, Kidney, Patent, Biosolids, Government, Cosmetics

Present disposal options for PFAS liquids include deep wells, incineration and landfills, all of which have serious environmental liability issues.

Key Points: 
  • Present disposal options for PFAS liquids include deep wells, incineration and landfills, all of which have serious environmental liability issues.
  • We expect that the Perma-Fix’s process will virtually eliminate PFAS compounds (minimum of 99.9999% destruction) and reduces the environmental liability associated with these materials.
  • Additionally, the process is designed to operate at a highly competitive price compared to traditional disposal options.
  • According to a recent article in Barron’s the estimated cleanup cost for PFAS compounds could exceed $200 billion.

MoneyHero Group Provides Guidance for Over $100 Million in Annual Revenue and Profitability in 2024; Elevates Shravan Thakur to Chief Commercial Officer to Support Growth and Expand Leadership Team

Retrieved on: 
Wednesday, April 3, 2024
American Express, PwC, Growth, Learning, Partnership, TransUnion, Commercial, CCO, Yoy, Investment, Tutoring

SINGAPORE, April 03, 2024 (GLOBE NEWSWIRE) -- MoneyHero Limited (NASDAQ: MNY) (“MoneyHero” or the “Company”), a market-leading personal finance and digital insurance aggregation and comparison platform in Greater Southeast Asia, today announced the promotion of distinguished global executive, Shravan Thakur, to Chief Commercial Officer (“CCO”), effective March 20, 2024. Prior to this appointment, Mr. Thakur had previously served as MoneyHero’s Group Co-Head of Commercial since November 2022, where he oversaw the Company’s commercial strategies in Hong Kong and Taiwan, as well as the formation of a strategic partnership with TransUnion for MoneyHero’s pivotal credit scoring offerings. He joined the Company in April 2021 as the General Manager of Hong Kong.

Key Points: 
  • Mr. Thakur brings more than 20 years of senior commercial and operational experience to this CCO role, including three years with MoneyHero.
  • Prior to joining the Company, Mr. Thakur previously held executive roles with several prominent global companies, including American Express and PricewaterhouseCoopers.
  • His areas of expertise include growth and transformational strategies, business development, P&L management, partnership programs, team building, and broader corporate affairs.
  • In the key markets of Singapore and Hong Kong, MoneyHero saw over 130% and 40% YoY Q4 revenue growth, respectively1.

Sunshine Minting, Inc. Adds Key Industry Expert to Management Team, Dr. Michael H. Gradwell

Retrieved on: 
Tuesday, April 2, 2024
Health, Comment, Growth, Commercial, Sunshine Minting, Plastic, Safety, Operation, SMI, Production, Management

Dr. Gradwell brings extensive experience in manufacturing and quality systems including possessing a Ph.D. in Physical Polymer chemistry and an MBA in Marketing and Leadership.

Key Points: 
  • Dr. Gradwell brings extensive experience in manufacturing and quality systems including possessing a Ph.D. in Physical Polymer chemistry and an MBA in Marketing and Leadership.
  • Tom Power, CEO of Sunshine Minting, Inc., had the following comment regarding Dr. Gradwell, “The addition of Dr. Gradwell brings a new level of technical depth and manufacturing expertise to our leadership team.
  • Mike possesses a deep understanding of manufacturing and quality systems, which will be the key to our continued growth as a company.
  • I am looking forward to welcoming Dr. Gradwell to our Team and introducing him to our Customers!”

Investor Notice: Robbins LLP Informs Investors of Class Action Filed Against bluebird bio, Inc. (BLUE)

Retrieved on: 
Saturday, March 30, 2024
Sickle cell disease, Biotechnology, Bluebird, Clinical, SAN, DSM-IV codes, Patient, History, News, LLP, Cancer, Commercial, Complaint, BLUE, File, SCD, FDA, BLA, Bluebird bio, Food, Person, Pharmaceutical industry

SAN DIEGO, March 30, 2024 (GLOBE NEWSWIRE) -- Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired bluebird bio, Inc. (NASDAQ: BLUE) common stock between April 24, 2023 and December 8, 2023.

Key Points: 
  • SAN DIEGO, March 30, 2024 (GLOBE NEWSWIRE) -- Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired bluebird bio, Inc. (NASDAQ: BLUE) common stock between April 24, 2023 and December 8, 2023.
  • Bluebird is a biotechnology company that researches, develops, and commercializes gene therapies for severe genetic diseases.
  • For more information, submit a form , email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.
  • A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation.

Dime Announces Availability of Zelle® for Business Customers

Retrieved on: 
Friday, March 29, 2024
Business, DCOM, Dime, Dime Community Bank, Commercial

HAUPPAUGE, N.Y., March 29, 2024 (GLOBE NEWSWIRE) -- Dime Community Bancshares, Inc. (NASDAQ: DCOM) (the “Company” or “Dime”), the parent company of Dime Community Bank (the “Bank”) announced today the launch of Zelle® for Business.

Key Points: 
  • HAUPPAUGE, N.Y., March 29, 2024 (GLOBE NEWSWIRE) -- Dime Community Bancshares, Inc. (NASDAQ: DCOM) (the “Company” or “Dime”), the parent company of Dime Community Bank (the “Bank”) announced today the launch of Zelle® for Business.
  • Commenting on the launch of Zelle® for Business, Michael Fegan, Chief Technology and Operations Officer at Dime said “We are very excited to launch Zelle® for business today.
  • It reinforces Dime’s commitment to bring top-tier technology and solutions to our Private & Commercial banking customers.
  • Our business customers will gain the ability to have payments sent directly to their eligible Dime Business Checking account, typically within minutes.”

KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

Retrieved on: 
Friday, March 29, 2024
Retina, Chair, Three Months, Biologics license application, Secretome, Disease, Infection, Incidence, Paratriathlon, Inflammation, Patient, Sale, Limbal stem cell, Research, CIRM, Acquisition, Commercial, Eye, Safety, Retinitis pigmentosa, Food, FDA, BLA, Stargardt disease, Physician, Contingency, Protease, Cryptocurrency

ARLINGTON, Mass., March 29, 2024 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare and severe diseases of the eye, today reported financial results for the fourth quarter and full year ended December 31, 2023 and provided a corporate update.

Key Points: 
  • “In 2023, we focused on clinical execution, advancing our Phase 2b CHASE trial of KPI-012 for the treatment of PCED.
  • In December 2023 and March 2024, KALA announced private placement financings with an institutional investor, priced at-the-market under Nasdaq rules.
  • Cash Position: As of December 31, 2023, KALA had cash and cash equivalents of $50.9 million, compared to $56.1 million as of September 30, 2023.
  • Operating Loss: For the quarter ended December 31, 2023, loss from operations was $9.6 million, compared to $10.3 million for the same period in 2022.

Gouverneur Bancorp, Inc. Announces Appointment of New President and Chief Executive Officer

Retrieved on: 
Wednesday, March 27, 2024
First Niagara Bank, Bank, Commercial, GS, OTCQB, Credit union

GOUVERNEUR, N.Y., March 27, 2024 (GLOBE NEWSWIRE) -- Gouverneur Bancorp, Inc. (OTCQB Marketplace: GOVB) (the “Company”), the holding company for Gouverneur Savings and Loan Association (the “Bank”), announced today that the Board of Directors of the Company and the Bank has appointed Robert W. Barlow as the President and Chief Executive Officer of the Company and the Bank effective immediately.

Key Points: 
  • GOUVERNEUR, N.Y., March 27, 2024 (GLOBE NEWSWIRE) -- Gouverneur Bancorp, Inc. (OTCQB Marketplace: GOVB) (the “Company”), the holding company for Gouverneur Savings and Loan Association (the “Bank”), announced today that the Board of Directors of the Company and the Bank has appointed Robert W. Barlow as the President and Chief Executive Officer of the Company and the Bank effective immediately.
  • Charles C. Van Vleet, Jr. will continue to serve as the President and Chief Executive Officer of GS&L Municipal Bank, the wholly owned subsidiary of the Bank, and will assist with Mr. Barlow’s transition to the role of President and Chief Executive Officer.
  • Mr. Barlow has served as Vice President of Commercial and Residential Lending for Northern Credit Union, located in Watertown, New York, since September 2019.
  • Mr. Barlow also served as Vice President and Branch Manager for First Niagara Bank, N.A.